BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34667108)

  • 1. Glioblastoma Cell-Derived lncRNA-Containing Exosomes Induce Microglia to Produce Complement C5, Promoting Chemotherapy Resistance.
    Li Z; Meng X; Wu P; Zha C; Han B; Li L; Sun N; Qi T; Qin J; Zhang Y; Tian K; Li S; Yang C; Ren L; Ming J; Wang P; Song Y; Jiang C; Cai J
    Cancer Immunol Res; 2021 Dec; 9(12):1383-1399. PubMed ID: 34667108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lnc-TALC promotes O
    Wu P; Cai J; Chen Q; Han B; Meng X; Li Y; Li Z; Wang R; Lin L; Duan C; Kang C; Jiang C
    Nat Commun; 2019 May; 10(1):2045. PubMed ID: 31053733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
    Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma.
    Zhang Z; Yin J; Lu C; Wei Y; Zeng A; You Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):166. PubMed ID: 30992025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal transfer of miR‑25‑3p promotes the proliferation and temozolomide resistance of glioblastoma cells by targeting FBXW7.
    Wang J; Li T; Wang B
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34278448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal lncRNA-Mediated Intercellular Communication Promotes Glioblastoma Chemoresistance.
    Zhao W; Xie Q
    Cancer Immunol Res; 2021 Dec; 9(12):1372. PubMed ID: 34753770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma.
    Zhao J; Cui X; Zhan Q; Zhang K; Su D; Yang S; Hong B; Wang Q; Ju J; Cheng C; Li C; Wan C; Wang Y; Zhou J; Kang C
    Theranostics; 2024; 14(7):2835-2855. PubMed ID: 38773970
    [No Abstract]   [Full Text] [Related]  

  • 8. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma.
    Lu C; Wei Y; Wang X; Zhang Z; Yin J; Li W; Chen L; Lyu X; Shi Z; Yan W; You Y
    Mol Cancer; 2020 Feb; 19(1):28. PubMed ID: 32039732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.
    Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y
    Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC00511 facilitates Temozolomide resistance of glioblastoma cells via sponging miR-126-5p and activating Wnt/β-catenin signaling.
    Lu Y; Tian M; Liu J; Wang K
    J Biochem Mol Toxicol; 2021 Sep; 35(9):e22848. PubMed ID: 34328678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of p38 MAPK inhibitor with PD-L1 antibody effectively prolongs survivals of temozolomide-resistant glioma-bearing mice via reduction of infiltrating glioma-associated macrophages and PD-L1 expression on resident glioma-associated microglia.
    Dang W; Xiao J; Ma Q; Miao J; Cao M; Chen L; Shi Y; Yao X; Yu S; Liu X; Cui Y; Zhang X; Bian X
    Brain Tumor Pathol; 2021 Jul; 38(3):189-200. PubMed ID: 34231121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.
    Kim SS; Harford JB; Moghe M; Rait A; Pirollo KF; Chang EH
    Nucleic Acids Res; 2018 Feb; 46(3):1424-1440. PubMed ID: 29202181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma.
    Liu B; Zhou J; Wang C; Chi Y; Wei Q; Fu Z; Lian C; Huang Q; Liao C; Yang Z; Zeng H; Xu N; Guo H
    Cell Death Dis; 2020 May; 11(5):384. PubMed ID: 32439916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines.
    Liu Y; Xu N; Liu B; Huang Y; Zeng H; Yang Z; He Z; Guo H
    Oncotarget; 2016 Jul; 7(28):43835-43851. PubMed ID: 27270310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma.
    Yin J; Zeng A; Zhang Z; Shi Z; Yan W; You Y
    EBioMedicine; 2019 Apr; 42():238-251. PubMed ID: 30917935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heme Oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy.
    Rehman FU; Liu Y; Yang Q; Yang H; Liu R; Zhang D; Muhammad P; Liu Y; Hanif S; Ismail M; Zheng M; Shi B
    J Control Release; 2022 May; 345():696-708. PubMed ID: 35341901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy.
    Ho KH; Shih CM; Liu AJ; Chen KC
    Cancer Sci; 2022 Feb; 113(2):540-552. PubMed ID: 34897892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
    Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC
    Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA-associated competing endogenous RNA network analysis uncovered key lncRNAs involved in temozolomide resistance and tumor recurrence of glioblastoma.
    Nayak R; Mallick B
    J Mol Recognit; 2023 Dec; 36(12):e3060. PubMed ID: 37720935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated Macrophages.
    Chuang HY; Su YK; Liu HW; Chen CH; Chiu SC; Cho DY; Lin SZ; Chen YS; Lin CM
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31269723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.